NCT06312085 A Study to Assess the Clinical Success of Root Canal Treatment Using Novel Obturation Material.
| NCT ID | NCT06312085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lumendo AG |
| Condition | Endodontic Treatment |
| Study Type | INTERVENTIONAL |
| Enrollment | 63 participants |
| Start Date | 2024-06-07 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63 participants in total. It began in 2024-06-07 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is prospective, single-arm, non-randomized controlled trial to test the effectiveness, safety and performance of a novel dental obturation material. The main question sit answers is 1. To test the effectiveness of the Endofill device for root canal obturation up to 12-month follow-up period. 2. To test the performance of the Endofill device evaluated with periapical radiographs immediately on completion of procedure. The participants requiring root canal treatment will be treated with obturated using Endofill material and post-treatment follow-up vistis will be conducted for 1 year. This is a single-arm study with no comparison groups.
Eligibility Criteria
Inclusion Criteria: • Patients aged 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2. ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body Mass Index) under 30, a non-smoking patient with good exercise tolerance. ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker). * Patients who agreed to participate and who have signed the informed consent. * Patients presenting with symptomatic and/or asymptomatic apical periodontitis and radiographic evidence of apical periodontitis in anterior or posterior teeth larger than 1.5 mm in diameter. * Mature tooth with closed apices. * Tooth that has never been treated with root canal therapy. Exclusion Criteria: * Patients who have pre-existing health or oral conditions that placed them at risk during the trial. * Patients with generalized untreated periodontal disease. * Patients with a history of analgesic intake within the past 3 days or antibiotics in the last 1 month. * Uncooperative patients. * Teeth with immature apices, root resorption, or requiring extensive prosthetic rehabilitation. * Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth). * Teeth with insufficient periodontal support. * Teeth with poor prognosis for root canal treatment, for example due to deep root caries, large root resorption or open apex cases. * Fractured teeth * Local anatomical factors such as an inaccessible root end * Presence of fractured instrument in the root canal * Pregnant women * Patients unable to understand the study procedure.
Contact & Investigator
Tan Firat Eyuboglu, Prof. Dr.
PRINCIPAL INVESTIGATOR
Medipol University
Frequently Asked Questions
Who can join the NCT06312085 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Endodontic Treatment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06312085 currently recruiting?
Yes, NCT06312085 is actively recruiting participants. Contact the research team at anupama.tripathi@odne.co for enrollment information.
Where is the NCT06312085 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06312085 clinical trial?
NCT06312085 is sponsored by Lumendo AG. The principal investigator is Tan Firat Eyuboglu, Prof. Dr. at Medipol University. The trial plans to enroll 63 participants.